Treatment of refractory acute leukemia with timed sequential chemotherapy using topotecan followed by etoposide + mitoxantrone (T-EM) and correlation with topoisomerase II levels
M. G. Mainwaring, L. M. Rimsza, S. F. Chen, S. P. Gomez, F. W. Weeks, V. Reddy, J. Lynch, W. S. May, S. Kahn, J. Moreb, H. Leather, R. Braylan, T. C. Rowe, K. J. Finiewicz, J. R. Wingard
Dive into the research topics of 'Treatment of refractory acute leukemia with timed sequential chemotherapy using topotecan followed by etoposide + mitoxantrone (T-EM) and correlation with topoisomerase II levels'. Together they form a unique fingerprint.